What is Regenxbio's investing cash flow?

Regenxbio (RGNX) reported investing cash flow of $70.59M in Q1 2026.

How has Regenxbio's investing cash flow changed year-over-year?

Regenxbio's investing cash flow increased by 57.8% year-over-year, from $44.74M to $70.59M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Regenxbio RGNX Investing Cash Flow

Investing Cash Flow at other companies

Regeneron PharmaceuticalsREGN

-$428.9M-166%

Sarepta Therapeutics, Inc.SRPT

-$134.39M+53.8%

BiogenBIIB

-$209.5M-343%

BioMarin PharmaceuticalsBMRN

$725.53M+2,669%

EyePoint, Inc. EYPT

$59.05M+49.4%

Ultragenyx PharmaceuticalRARE

-$49M-141%

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's investing cash flow?: Regenxbio (RGNX) reported investing cash flow of $70.59M in Q1 2026.
How has Regenxbio's investing cash flow changed year-over-year?: Regenxbio's investing cash flow increased by 57.8% year-over-year, from $44.74M to $70.59M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.